200 related articles for article (PubMed ID: 18973684)
1. A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum.
Le Roch KG; Johnson JR; Ahiboh H; Chung DW; Prudhomme J; Plouffe D; Henson K; Zhou Y; Witola W; Yates JR; Mamoun CB; Winzeler EA; Vial H
BMC Genomics; 2008 Oct; 9():513. PubMed ID: 18973684
[TBL] [Abstract][Full Text] [Related]
2. Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
Richier E; Biagini GA; Wein S; Boudou F; Bray PG; Ward SA; Precigout E; Calas M; Dubremetz JF; Vial HJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3381-8. PubMed ID: 17005821
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinases.
Alberge B; Gannoun-Zaki L; Bascunana C; Tran van Ba C; Vial H; Cerdan R
Biochem J; 2009 Dec; 425(1):149-58. PubMed ID: 19845508
[TBL] [Abstract][Full Text] [Related]
4. Effect of a bis-thiazolium compound on the biosynthesis of Plasmodium falciparum phospholipids.
Ahiboh H; Djaman AJ; Yapi FH; Edjeme-Aké A; Hauhouot-Attoungbré ML; Yayo ED; Monnet D
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):911-7. PubMed ID: 19235542
[TBL] [Abstract][Full Text] [Related]
5. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death.
Serrán-Aguilera L; Denton H; Rubio-Ruiz B; López-Gutiérrez B; Entrena A; Izquierdo L; Smith TK; Conejo-García A; Hurtado-Guerrero R
Sci Rep; 2016 Sep; 6():33189. PubMed ID: 27616047
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae.
Roggero R; Zufferey R; Minca M; Richier E; Calas M; Vial H; Ben Mamoun C
Antimicrob Agents Chemother; 2004 Aug; 48(8):2816-24. PubMed ID: 15273086
[TBL] [Abstract][Full Text] [Related]
8. Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria.
Makanga M; Bray PG; Horrocks P; Ward SA
Proteomics; 2005 May; 5(7):1849-58. PubMed ID: 15832369
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
Radfar A; Diez A; Bautista JM
Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
[TBL] [Abstract][Full Text] [Related]
10. In vivo transcriptional profiling of Plasmodium falciparum.
Daily JP; Le Roch KG; Sarr O; Fang X; Zhou Y; Ndir O; Mboup S; Sultan A; Winzeler EA; Wirth DF
Malar J; 2004 Aug; 3():30. PubMed ID: 15296511
[TBL] [Abstract][Full Text] [Related]
11. Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate.
Natalang O; Bischoff E; Deplaine G; Proux C; Dillies MA; Sismeiro O; Guigon G; Bonnefoy S; Patarapotikul J; Mercereau-Puijalon O; Coppée JY; David PH
BMC Genomics; 2008 Aug; 9():388. PubMed ID: 18706115
[TBL] [Abstract][Full Text] [Related]
12. Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.
Wein S; Maynadier M; Bordat Y; Perez J; Maheshwari S; Bette-Bobillo P; Tran Van Ba C; Penarete-Vargas D; Fraisse L; Cerdan R; Vial H
Br J Pharmacol; 2012 Aug; 166(8):2263-76. PubMed ID: 22471905
[TBL] [Abstract][Full Text] [Related]
13. Functional genomics, new tools in malaria research.
Di Girolamo F; Raggi C; Bultrini E; Lanfrancotti A; Silvestrini F; Sargiacomo M; Birago C; Pizzi E; Alano P; Ponzi M
Ann Ist Super Sanita; 2005; 41(4):469-77. PubMed ID: 16569915
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects.
Witola WH; El Bissati K; Pessi G; Xie C; Roepe PD; Mamoun CB
J Biol Chem; 2008 Oct; 283(41):27636-27643. PubMed ID: 18694927
[TBL] [Abstract][Full Text] [Related]
15. Whole-transcriptome analysis of Plasmodium falciparum field isolates: identification of new pathogenicity factors.
Siau A; Toure FS; Ouwe-Missi-Oukem-Boyer O; Ciceron L; Mahmoudi N; Vaquero C; Froissard P; Bisvigou U; Bisser S; Coppee JY; Bischoff E; David PH; Mazier D
J Infect Dis; 2007 Dec; 196(11):1603-12. PubMed ID: 18008243
[TBL] [Abstract][Full Text] [Related]
16. Effect of choline kinase inhibitor hexadecyltrimethylammonium bromide on Plasmodium falciparum gene expression.
Razak MR; Abdullah NR; Chomel R; Muhamad R; Ismail Z
Southeast Asian J Trop Med Public Health; 2014 Mar; 45(2):259-66. PubMed ID: 24968665
[TBL] [Abstract][Full Text] [Related]
17. Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones.
Nogueira F; Diez A; Radfar A; Pérez-Benavente S; do Rosario VE; Puyet A; Bautista JM
Acta Trop; 2010 May; 114(2):109-15. PubMed ID: 20138820
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum CTP:phosphocholine cytidylyltransferase possesses two functional catalytic domains and is inhibited by a CDP-choline analog selected from a virtual screening.
Contet A; Pihan E; Lavigne M; Wengelnik K; Maheshwari S; Vial H; Douguet D; Cerdan R
FEBS Lett; 2015 Apr; 589(9):992-1000. PubMed ID: 25771858
[TBL] [Abstract][Full Text] [Related]
19. Anti-Plasmodium activity of ceramide analogs.
Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
[TBL] [Abstract][Full Text] [Related]
20. Natural antisense transcripts in Plasmodium falciparum isolates from patients with complicated malaria.
Subudhi AK; Boopathi PA; Garg S; Middha S; Acharya J; Pakalapati D; Saxena V; Aiyaz M; Orekondy HB; Mugasimangalam RC; Sirohi P; Kochar SK; Kochar DK; Das A
Exp Parasitol; 2014 Jun; 141():39-54. PubMed ID: 24657575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
